Join
Live feed
·
INSIDERFilingvia Quantisnow
Eliem Therapeutics Inc logo

Director Thomas Stephen Basil was granted 103,907 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELYM· Eliem Therapeutics Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELYM (Eliem Therapeutics Inc) and more on Quantisnow.

Director Thomas Stephen Basil was granted 103,907 shares (SEC Form 4) | Quantisnow